Clinical Immunoassay Analyzer Market Forecast 2016-2020. The recent market report from Technavio predicts that the U.S. clinical immunoassay analyzer market will grow at a CAGR of 6.04 percent during the period 2016-2020.
To calculate market size, the report considered the revenue generated from the sales of these analyzers. The market is driven by the increasing need for quality immunoassay analyzers to perform testing for cancer markers, diagnosis of infectious diseases such as human immunodeficiency virus (HIV) and hepatitis, cardiac analysis, therapeutic drug monitoring and allergy testing. Today’s automated analyzers can efficiently organize testing to achieve maximum throughput. They can process multiple samples simultaneously with unique diluent and ratio requirements, and provide multiple results from one sample.
They can initiate the precise and proper testing from an entire menu of assays, applying proper diluents – all without requiring laboratory personnel for sorting and organizing. (Visited 35 times, 2 visits today) U.S. Immunoassay Clinical Analyzer Market Growth - 2016-2020. A recent market research report from Technavio predicts that the U.S. immunoassay clinical analyzer market will grow at a healthy CAGR of around 6% during 2016 – 2020.
Today, immunoassay analyzers are available as floor and benchtop models. Modern devices offer comprehensive testing for infectious diseases, thyroid, fertility and anemia, as well as assays for cancer markers, cardiac analysis, allergy testing and therapeutic drug monitoring. Modern devices come with a wide range of advanced features such as a comprehensive disease-focused menu, streamlined sample handling, continuous sample loading, simplified operation, and excellent precision and sensitivity. Blood Gas and Electrolyte Analyzer Market Growing Rapidly. According to a recent survey by Transparency Market Research, the global blood gas and electrolyte analyzer market, which was valued at US$1.44 billion in 2014, will reach US$3.48 billion in 2023 at a CAGR of 9.66 % from 2015 to 2023.
Ranging from single parameter table-top devices to compact point-of-care devices, blood gas and electrolyte analyzers are versatile lab instruments. While blood gas analyzers measure the amount of oxygen and carbon dioxide in the blood, electrolyte analyzers determine electrolyte levels in the human body to detect metabolic imbalances and measure renal and cardiac function.
These tests help in the detection of various diseases such as asthma, chronic obstructive pulmonary disease (COPD), kidney failure, heart failure, uncontrolled diabetes, severe infections, and drug overdose. The demand for handheld analyzers has fuelled the market growth. North America Dominates Global Clinical Analyzer Market. Clinical chemistry testing has advanced dramatically in recent years and the market for clinical chemistry analyzers is growing.
According to a recent market report from Persistence Market Research, the key factors driving the global demand for these devices are: rising aging population, increasing number of reagent rental agreements, rising number of lifestyle associated disorders, rising per capita income in developing countries, and increased health care awareness.
The report also indicates that North America dominates the global clinical analyzer market, followed by Europe. The reasons for the dominance of these regions are: Rising prevalence of infectious and non-infectious diseasesIncreased demand for laboratory automation in clinical laboratoriesExpansion in the number of people with health insurance, especially in the U.S. Hematology Diagnostic Device Market to Grow. Various factors are working to fuel the growth of the global hematology diagnostics market, according to a recent Persistence Market Research (PMR) report.
The use of hematology diagnostics has increased in recent years due to rising incidence of blood disorder diseases. This, in turn, has increased the demand for hematology analyzers and reagents that can provide accurate and timely results for efficient patient management. There are various types of blood disorders such as platelet disorders, excessive clotting, and bleeding problems (hemostatis); anemia; leukemia and myeloma which are cancers of the blood, and eosinophilic disorders, which refer to problems with one white blood cell type. Global DOA Testing Market to Hit $3.9 B by 2020. According to the P&S Market Research report, the global drug of abuse testing market is expected to reach $3.9 billion in 2020.
Major factors that lead to the growth of DOA testing are increased use of illicit drugs and the need of testing at organizational level. Drug testing is mainly recommended for medical, legal as well as sports screening purposes. Blood, urine or other lab tests are used to assess drug use and monitor treatment related to drug addiction. It is recommended that laboratories conduct an initial screening test followed by a confirmatory test on the sample before the specimen can be reported as positive. Global Blood Gas & Electrolyte Analyzer Market Growing. According to a new report from Technavio, the global market for blood gas and electrolyte analyzers is expected to grow at a CAGR of over 6% from 2014-2019.
The report also emphasizes a shift from benchtop analyzers to portable analyzers by end-users because of the latter’s efficiency and accurate results. Blood gas analysis or arterial blood gas (ABG) analysis is often recommended to detect lung disease, kidney disease, metabolic disease, head or neck injuries that affect breathing. The tests may be ordered along with electrolytes to detect electrolyte imbalance, glucose to measure blood sugar concentrations, and BUN and creatinine tests to assess kidney function.
Blood gas analyzers measure: Point-Of-Care Diagnostics Market to Reach $18.7B By 2020. Point-of-care testing (POCT) allows rapid diagnosis in the physician’s office, an ambulance, the home, the field, or in the hospital, and promotes timely patient care.
With POCT, physicians as well as patients no longer have to wait hours to get results. Over the past few years, the popularity and demand of POCT has been growing rapidly. Cancer Biomarkers Market - Global Forecast 2015-2020. According to a recent report from Markets and Markets, the global cancer biomarkers market is expected to reach USD 15,973.8 million by 2020, at a CAGR of 11.6% from 2015 to 2020.
Cancer biomarkers refer to the proteins, genes and other molecules that affect how cancer cells grow, multiply, die and react to other compounds in the body. With technological advancements, knowledge about cancer biomarkers has increased significantly in recent years. Researchers are focused on developing new biomarkers for cancer drug discovery and development, diagnostics, personalized medicine, and therapeutics. The Markets and Markets report segments the cancer biomarkers market based on – According to the report, the growth of the cancer biomarkers market is driven by the following factors: The leading players in the cancer biomarkers market are Abbott Laboratories (U.S.), Affymetrix Inc.
More than 11 million people are diagnosed with cancer every year. (Visited 23 times, 11 visits today) Global Microscopy Device Market to Exceed $9 billion by 2020. According to a recent report from Technavio, the global microscopy device market is will reach over USD 9 billion by 2020, growing at a CAGR of around 7% during the forecast period starting 2015.
Blood Processing Devices and Consumables Market Set to Grow. Blood processing devices and consumables are essential in the healthcare industry with new blood-related disorders and infections emerging day by day. Blood transfusion is a regular procedure in hospitals, which requires these products. Unsafe blood transfusion can lead to the spread of dangerous diseases. Global In Vitro Diagnostics Market Witnessing Rapid Growth. In vitro diagnostics (IVDs) are medical devices and accessories used to perform tests on blood, urine and tissue samples from the human body to detect infection, diagnose a medical condition, prevent disease, and monitor drug therapies. A recent report from Markets and Markets says that the global in vitro diagnostics market is expected to reach $75.1 billion by 2020, growing at a CAGR of 5.8% from 2015 to 2020.
Major factors that drive the growth of this market are The rising incidences of chronic lifestyle diseases across the globeGrowing aging populationIncreasing usage of point-of-care testing and personalized medicine However, the report states that inadequate budget and limited reimbursement are restraining the growth of this market. Global Cell Counting Market to Reach $8.6 Billion by 2020.
Evaluating the cellular components of blood allows detection of numerous medical conditions. The complete blood count (CBC) indicates variations in the numbers and appearance of red blood cells, white blood cells), and platelets from their predictable, ‘normal’ state can indicate the presence of disease. Global Immunoassay Market to Grow at CAGR of 9.7% in 2019.
Modern immunoassay systems are designed to perform a wide range of clinical tests and help detect several diseases. Global Lab Accessories Market Forecast to 2020. Laboratories require high quality equipment to deliver accurate, consistent and quick results. With more and more hospitals and research institutes choosing to automate their testing laboratories, demand for laboratory accessories is set to rise in the near future, says a recent report from Markets and Markets. A survey conducted by the editors of Laboratory Equipment magazine last year confirms the trend towards automation in laboratories in the U.S. Global Lab Automation Market to reach $5,105.7M by 2020.